The global neonatal infant care market size was USD 3.16 billion in 2023, calculated at USD 3.39 billion in 2024 and is expected to be worth around USD 6.70 billion by 2034. The market is slated to expand at 7.04% CAGR from 2024 to 2034
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Neonatal Infant Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Neonatal Infant Care Market Revenue and Volume, By Product Type, 2024-2034
8.1.1 Thermoregulation Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Phototherapy Devices
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Monitoring Systems
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Neonatal Hearing Screening
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Neonatal Infant Resuscitator Devices
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1.6. Vision Screening
8.1.6.1. Market Revenue and Volume Forecast (2021-2034)
8.1.7. Others
8.1.7.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Neonatal Infant Care Market Revenue and Volume, By End-use, 2024-2034
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Nursing Homes
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Pediatric & Neonatal Clinics
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.1.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.2.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.3.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.4.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.5.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Product Type (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, By End-use (2021-2034)
11.1. GE Healthcare
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Koninklijke Philips N.V
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Medtronic plc
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Natus Medical Incorporated
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Fisher & Paykel Healthcare Limited
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Masimo Corporation'
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Becton
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Dickinson and Company
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Phoenix Medical Systems (P) Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Novos Medical Systems
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample